APOG's total debt skyrocketed 360% to $285M while operating cash flow plummeted 39%, creating a concerning deterioration in financial leverage and cash generation.
The massive debt increase combined with sharply declining operating cash flow and reduced net income suggests either a major acquisition or significant operational stress. Despite lower interest expense (likely due to timing), the company's ability to service this dramatically higher debt load is questionable given the weaker cash generation.
APOG shows signs of financial strain with total debt exploding from $62M to $285M (+360%) while operating cash flow declined 39% to $125M and net income fell 15% to $85M. The company expanded its balance sheet significantly with total assets growing 33% and inventory up 33%, but this growth appears debt-financed rather than organically generated. The combination of massive debt increase, declining profitability, and weakened cash flow represents a material deterioration in financial health that investors should closely monitor.
Debt increased 359.7% — substantial leverage increase; assess whether deployed for growth or covering losses.
Share repurchases increased 283.8% — management returning capital, signals confidence in intrinsic value.
Operating cash flow fell 38.7% — earnings quality concerns; investigate working capital changes and non-cash items.
Inventory surged 33.3% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.
Asset base grew 32.9% — expansion through organic growth, acquisitions, or capital deployment.
Current assets grew 23.3% — improving short-term liquidity or inventory/receivables build.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Current liabilities rose 16.7% — increased short-term obligations, watch current ratio.
Net income declined 14.6% — review whether driven by operations, interest costs, or non-recurring items.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →